US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
USOTC
Ypsomed Hodling AG (PK) (YPHDF) 銘柄情報

Ypsomed Hodling AG (PK) (YPHDF)

430.00

0.00

(0.00%)

終了 7月3日 5:00AM

Ypsomed Hodling AG (PK) (YPHDF) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

430.00

( - )

買値

0.01

売値

287,223.47

出来高

-

0.00 日の範囲 0.00

354.924 52 週間の範囲 535.75

時価総額

前日終値

430.00

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

US$ 18,853

発行済株式数

13,146,952

配当利回り

4.4 (1.29%)

PER

22.09

1 株当たり利益 (EPS)

16.3

歳入

730.98M

純利益

221.93M

Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication in Switzerland, Europe, North America, and internationally. The company offers various injection systems, such as pen injectors, auto-injectors, an... Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication in Switzerland, Europe, North America, and internationally. The company offers various injection systems, such as pen injectors, auto-injectors, and wearable injectors, as well as other related services. It offers contract manufacturing of infusion sets and reservoirs. The company markets its products to hospitals, doctors, pharmacies and patients via subsidiaries and distributors. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland. 詳細を表示

セクター

Healthcare

業界

Medical Equipment & Supplies

ウェブサイト

www.ypsomed.com

本社

Burgdorf, Switzerland

設立

1984

Ypsomed Hodling AG (PK) is listed in the Healthcare sector of the その他OTC with ticker YPHDF. The last closing price for Ypsomed Hodling (PK) was US$430. Over the last year, Ypsomed Hodling (PK) shares have traded in a share price range of US$ 354.924 to US$ 535.75.

Ypsomed Hodling (PK) currently has 13,146,952 shares in issue. The market capitalisation of Ypsomed Hodling (PK) is US$5.65 billion. Ypsomed Hodling (PK) has a price to earnings ratio (PE ratio) of 22.09.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	-9.364	-2.13126246119	439.364	439.364	426.145	21	428.72409524	CS
12	75.076	21.1526974789	354.924	439.364	354.924	11	428.72409524	CS
26	37.98	9.68828121014	392.02	439.364	354.924	13	394.59134328	CS
52	-93.28	-17.8260204862	523.28	535.75	354.924	28	487.99732513	CS
156	147.592	52.2619755814	282.408	535.75	261	35	423.84758042	CS
260	315.6184	275.934590878	114.3816	535.75	114.3816	34	400.7880436	CS

YPHDF - Frequently Asked Questions (FAQ)

What is the current Ypsomed Hodling AG (PK) share price?

The current share price of Ypsomed Hodling AG (PK) is US$ 430.00

How many Ypsomed Hodling AG (PK) shares are in issue?

Ypsomed Hodling AG (PK) has 13,146,952 shares in issue

What is the market cap of Ypsomed Hodling AG (PK)?

The market capitalisation of Ypsomed Hodling AG (PK) is USD 5.65B

What is the 1 year trading range for Ypsomed Hodling AG (PK) share price?

Ypsomed Hodling AG (PK) has traded in the range of US$ 354.924 to US$ 535.75 during the past year

What is the PE ratio of Ypsomed Hodling AG (PK)?

The price to earnings ratio of Ypsomed Hodling AG (PK) is 22.09

What is the cash to sales ratio of Ypsomed Hodling AG (PK)?

The cash to sales ratio of Ypsomed Hodling AG (PK) is 6.47

What is the registered address of Ypsomed Hodling AG (PK)?

The registered address for Ypsomed Hodling AG (PK) is Brunnmattstrasse 6, Burgdorf, Bern, 3401

What is the Ypsomed Hodling AG (PK) website address?

The website address for Ypsomed Hodling AG (PK) is www.ypsomed.com

Which industry sector does Ypsomed Hodling AG (PK) operate in?

Ypsomed Hodling AG (PK) operates in the Medical Equipment & Supplies sector

sage007

sage007 5分前

The fact that you take my first line and edit it to suit your narrative was enough for me to not read whatever you were spouting in your professorially long essay. The substance of it must have been no more than a pile of cow dung. I didn’t read it. Not worth the time and effort.

FlashySage44

FlashySage44 26分前

Why would the stock disappear after a reverse split?
It would be reversing into strength.
It has great fundamentals. It’s a great defensive healthcare play.
Yes it would struggle at first due to reverse split aversion, but in the long term, it would be great for us.

ulmadi

ulmadi 36分前

Thanks for the correction.

Go NEWH

axelvento

axelvento 37分前

Trump’s Newly Disclosed Moderna Trades Preceded FDA Advisory Panel’s Unanimous Backing of mRNA Flu Vaccine

The filings show Trump purchased Moderna ($MRNA) on March 2 ($15,001-$50,000) and again on March 17 ($1,001-$15,000), before reporting a $1,001-$15,000 sale on May 18.
Mod

Methinks

Methinks 48分前

Likewise, buddy!

EZ2

Awesome ~~~~ great guy !! 🇺🇸

t1215s

t1215s 1時間前

I will address LOCH & LOCK BROKE aka Joseph Grimaldi & Emmett Kelly Monday 😉

To all enjoy our Nation’s 250th..Ts-🍻😎🇺🇸

Golfnut3

Golfnut3 1時間前

That's all I know, I saw it on one of the Facebook group pages...

AngeloFoca

AngeloFoca 1時間前

NWBO management, as I have said could engage in confidence building to help shareholders stay in but that would require them to care about the SP.

Linda is by far the largest shareholder, and all who work there, I'm sure, hold sizeable positions... But you think they don't care about

Seminole Red

Seminole Red 2時間前

Ruined VW’s - purist not allowed

Almost positive it’s ruined.

https://www.facebook.com/reel/1768850754281751

Ray_137

Ray_137 2時間前

Any news about the date of 30th June 2026?

SkeBallLarry

SkeBallLarry 2時間前

% Happy 4th to you, Getmore ~ Thanks 4 All % ..

OliXPharma_Official

OliXPharma_Official 2時間前

Global pharma interest in RNAi therapeutics continues to accelerate.

According to BioSpace, AstraZeneca has entered into a collaboration with CSPC Pharmaceutical Group to discover and develop siRNA therapeutics for kidney diseases. The deal is reportedly worth up to $1.77 billion, inc

Pittsburgh Boy

Pittsburgh Boy 2時間前

Umm no that's why I asked, thanks

diamondguru-one

diamondguru-one 2時間前

On September 30th…

President Trump is set to declare this miracle material a national strategic resource. And ban it as a U.S. expor t.

That means every major tech company on the planet will be forced to come here — to U.S. soil — to get it.

Apple, NVI

sentiment_stocks

sentiment_stocks 2時間前

If the mOS of the control arm drops, wouldn’t that increase the difference between the two?

I do wonder if the MAIC was, in the end, simply more conservative due to its weighting than the patient level scoring?

Kool Aid Man

Kool Aid Man 3時間前

Gullible goobers actually believe they'd own Patagroania..smh

BeachBum

BeachBum 3時間前

30 mil, pay attention.

europa7

europa7 3時間前

Europe's MiCA Deadline Leaves Four in Five Crypto Firms Without a Licence
1 July 2026
https://www.sandmark.com/news/features/europes-mica-deadline-leaves-four-five-crypto-firms-without-licence

"...The transitional window closed on 1 Jul, and the grace period that let nat

GseHeist

GseHeist 3時間前

Looks like AL4ZR is playing F2 soccer on the FiFA sidelines. Very very dangerous game he is playing and he doesn't belong here.

nowwhat2

nowwhat2 3時間前

https://investorshub.advfn.com/uimage/uploads/2026/7/3/ljz[qbtc_july_2_10y_10pm_GEE_200_60.jpg

https://investorshub.advfn.com/uimage/uploads/2026/7/3/qbfzqbtc_july_2_1y_200_60k_zoom.jpg

https://investorshub.advfn.com/uimage/uploads/2026/7

along4zride

along4zride 3時間前

He is in a league the garden variety penny pinching stock holder cannot comprehend. There is little empathy for (FNMA) bottom feeders.Never has been and never will be .

Ypsomed Hodling (PK)

Agf Canadian Money Marke...

Southern Empire Resources

Westpac Banking

Ladenburg Thalmann Finan... (EM)

Woodside Energy (PK)

UBS Core MSCI EM UCITS ETF

GreenFirst Forest Products

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。